| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V107201 | Chenodeoxycholic acid 3-glucuronide | 58814-71-4 | Chenodeoxycholic acid 3-glucuronide is a metabolite of chenodeoxycholic acid, which can activate key nuclear receptors (FXR) with an EC50 of 8 μM and an EC50 of 11 μM for FXR activation in HEK293T cells. |
|
V104307 | FXR agonist 10 | FXR agonist 10 (Compound 27) is an agonist of FXR with an EC50 of 14.26 μM. | |
|
V115591 | FXR agonist 13 | FXR agonist 13 is a highly selective, orally effective, and potent FXR agonist (EC50 = 0.097 μM) with good hepatic microsomal metabolic stability. | |
|
V110955 | FXR agonist 15 | 2991276-14-1 | FXR agonist 15 is a selective, orally effective farnesoid X receptor (FXR) agonist with an EC50 value of 0.76 μM. |
|
V87447 | FXR agonist 3 | FXR agonist 3 is an anti-NASH agent that acts by activating FXR. | |
|
V87448 | FXR agonist 4 | 3025841-47-5 | FXR agonist 4 (compound 10a) is a farnesoid X receptor (FXR) agonist with an EC50 value of 1.05 μM. |
|
V74031 | FXRagonist 5 | 2414008-05-0 | FXR agonist 5 (compound 1) is an FXR agonist. |
|
V29731 | Gly-β-MCA | 66225-78-3 | Gly-β-MCA is a bile acid acting as an oral and potent farnesoid X receptor (FXR) inhibitor with the potential to be usedfor the treatment of metabolic disorders. |
|
V1841 | GW-4064 | 278779-30-9 | GW4064 (GW-4064) is a novel, potent and selective agonist of farnesoid X receptor (FXR) (EC50 of 65 nM in CV1 cell line) with potential usefulness in the treatment of cholestatic liver disease. |
|
V104460 | LZ-007 | 2920000-23-1 | LZ-007 LZ-007 is an agonist of farnesoid X receptor (FXR) with EC50 of 51 nM as determined by TR-FRET and EC50 of 76 nM for FXR in HepG2 cells. |
|
V141760 | Obeticholic acid-d4-1 | Obeticholic acid-d4-1 is a deuterated obeticholic acid. | |
|
V145622 | Tauro-obeticholic acid-d5 | Tauro-obeticholic acid-d5 is deuterated tauroobeticholic acid. | |
|
V1842 | Turofexorate Isopropyl (XL335) | 629664-81-9 | Turofexorate Isopropyl (also known as WAY-362450, Fxr 450 and XL335) is a novel, highly potent, selective and orally bioavailable FXR (farnesoid X receptor) agonist with EC50 of 4 nM, it is highly selective versus other nuclear receptors, such as LXR, PPAR, ER and etc. |
|
V1844 | Obeticholic Acid (6-ECDCA; INT-747) | 459789-99-2 | Obeticholic Acid (INT747; 6-ECDCA; 6-Ethylchenodeoxycholic acid; trade name Ocaliva), a novel derivative of cholic acid, is a potent,orally bioactive and selectiveagonist of farnesoid X receptor (FXR) with EC50 of 99 nM, and has anticholeretic and anti-inflammatory activities. |
|
V3701 | Tropifexor | 1383816-29-2 | Tropifexor (also known as LJN452) is a novel, potent and highly potent agonist of FXR (farnesoid X receptor) with an EC50 value of 0.2 nM in HTRF assay. |
|
V1843 | Lithocholic acid | 434-13-9 | Lithocholic acid (3α-Hydroxy-5β-cholanic acid), a secondary bile acid formed from chenodeoxycholate by bacterial action, acts as a detergent to solubilize fats for absorption and is itself absorbed. |